Abstract Background Patients with von Hippel-Lindau (VHL) disease are at risk of
developing tumors in the eye, brain, kidney, adrenal gland, and other organs based on their …

Objective: Pheochromocytomas are a hallmark feature of von Hippel-Lindau disease (vHL).
To our knowledge, this is the first systematic review with meta-analysis evaluating the …

The autosomal dominant von Hippel‐Lindau disease (vHL) is associated with a lifelong risk
of tumor development, especially retinal and CNS hemangioblastomas, pheochromocytoma …

Von Hippel–Lindau (VHL) disease is a rare autosomal-dominant inherited tumor syndrome.
We aimed to analyze the correlations between frequent VHL mutations and phenotypes in …

Abstract Context Von Hippel-Lindau (VHL) disease is an autosomal dominant syndrome
caused by germline mutations in the VHL gene. Guidelines recommend pheochromocytoma …

Abstract Von Hippel-Lindau (VHL) syndrome is a hereditary tumor syndrome associated with
germline loss-of-function pathogenic variants (PVs) in the VHL gene. VHL is classically …

The data in genotype-phenotype correlation in Indian von Hippel–Lindau (VHL) patients is
limited. We have retrospectively studied 31 genetically proven VHL patients with …

Retinal capillary hemangioblastomas (RCH) is a benign tumor that represents the initial
manifestation in roughly half of Von Hippel Lindau (VHL) patients. They may also occur …

Introduction Hereditary cancer predisposition syndromes are caused by germline
pathogenic or likely pathogenic variants in cancer predisposition genes (CPG). The majority …

Abstract Background Von Hippel–Lindau (VHL) syndrome is a familial cancer syndrome
caused by mutations in VHL gene. It is characterized by the formation of benign and …